Blog

Vitamin Supplements May Slow Glaucoma Progression, Study Finds Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. While treatments like eye drops, laser therapy, and surgery aim to lower intraocular pressure (IOP), researchers are constantly exploring new ways to slow disease progression. A recent study suggests that vitamin supplements could play […]

Perfuse Therapeutics Reports Positive Phase 1/2a Results for PER-001 Glaucoma Implant In a significant breakthrough for glaucoma treatment, Perfuse Therapeutics has announced encouraging results from its Phase 1/2a clinical trial for PER-001, a novel implant designed to manage intraocular pressure (IOP) in glaucoma patients. The study demonstrated both safety and efficacy, marking a promising step

How Intraoperative Fluorescein Angiography Enhances RWC 2025 Surgical Outcomes In the rapidly evolving field of surgical medicine, advancements in imaging technologies are revolutionizing patient outcomes. One such breakthrough is intraoperative fluorescein angiography (IFA), a real-time imaging technique that is transforming surgical precision, particularly in complex procedures like those anticipated in the RWC 2025 (Robotic and

Minimally Invasive Glaucoma Treatments Show Promising Advances Glaucoma, often called the “silent thief of sight,” is a leading cause of irreversible blindness worldwide. Traditional treatments like eye drops, laser therapy, and invasive surgeries have been the mainstay for decades. However, recent advancements in minimally invasive glaucoma treatments (MIGS) are revolutionizing how this condition is managed.

HELIOS Trial Insights: Dr. Dilsher S. Dhoot on Diabetic Retinopathy Breakthroughs Diabetic retinopathy (DR) remains one of the most common and devastating complications of diabetes, affecting millions worldwide. The HELIOS trial has emerged as a groundbreaking study, offering new hope for patients battling this vision-threatening condition. In this article, we delve into the key insights

Top Vitamin to Safeguard Your Eyesight, Says New Study Maintaining healthy eyesight is crucial for overall well-being, yet many people overlook the role of nutrition in protecting their vision. A new study has identified a key vitamin that plays a vital role in safeguarding eye health and preventing age-related vision problems. Whether you spend hours

Can High HDL Cholesterol Worsen Glaucoma Risk? Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. While high intraocular pressure (IOP) is a well-known risk factor, emerging research suggests that cholesterol levels—particularly high-density lipoprotein (HDL) cholesterol—may also play a role. But could high HDL cholesterol actually worsen glaucoma risk? Let’s explore

Preventable Glaucoma Vision Loss Hindered by Treatment Costs Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. Yet, what makes this condition even more tragic is that much of the vision loss it causes is preventable with timely diagnosis and treatment. Unfortunately, the high cost of glaucoma care creates significant barriers

National Reconstruction Fund Invests $27M in Glaucoma Treatment Innovation The National Reconstruction Fund (NRF) has announced a groundbreaking investment of $27 million into cutting-edge glaucoma treatment innovation. This significant funding aims to accelerate research, development, and commercialization of advanced therapies to combat glaucoma—a leading cause of irreversible blindness worldwide. The move underscores the government’s commitment

Understanding Age-Related Glaucoma Progression: Key Insights Glaucoma is a leading cause of irreversible blindness worldwide, particularly affecting older adults. As we age, the risk of developing glaucoma increases, making it crucial to understand how this condition progresses over time. Early detection and proper management can help preserve vision and improve quality of life. In this